The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
The glutamate story
Open accessAbstract
Glutamatergic synaptic transmission in the mammalian central nervous system was slowly established over a period of some 20 years, dating from the 1950s. Realisation that glutamate and like amino acids (collectively known as excitatory amino acids (EAA)) mediated their excitatory actions via multiple receptors preceded establishment of these receptors as synaptic transmitter receptors. EAA receptors were initially classified as N‐methyl‐D‐aspartate (NMDA) and non‐NMDA receptors, the latter subdivided into quisqualate (later AMPA) and kainate receptors after agonists that appeared to activate these receptors preferentially, and by their sensitivity to a range of differentially acting antagonists developed progressively during the 1970s. NMDA receptors were definitively shown to be synaptic receptors on spinal neurones by the sensitivity of certain excitatory pathways in the spinal cord to a range of specific NMDA receptor antagonists. Importantly, specific NMDA receptor antagonists appeared to be less effective at synapses in higher centres. In contrast, antagonists that also blocked non‐NMDA as well as NMDA receptors were almost universally effective at blocking synaptic excitation within the brain and spinal cord, establishing both the existence and ubiquity of non‐NMDA synaptic receptor systems throughout the CNS. In the early 1980s, NMDA receptors were shown to be involved in several central synaptic pathways, acting in concert with non‐NMDA receptors under conditions where a protracted excitatory postsynaptic potential was effected in response to intense stimulation of presynaptic fibres. Such activation of NMDA receptors together with non‐NMDA receptors led to the phenomenon of long‐term potentiation (LTP), associated with lasting changes in synaptic efficacy (synaptic plasticity) and considered to be an important process in memory and learning. During the 1980s, it was shown that certain glutamate receptors in the brain mediated biochemical changes that were not susceptible to NMDA or non‐NMDA receptor antagonists. This dichotomy was resolved in the early 1990s by the techniques of molecular biology, which identified two families of glutamate‐binding receptor proteins (ionotropic (iGlu) and metabotropic (mGlu) receptors). Development of antagonists binding to specific protein subunits is currently enabling precise identification of discrete iGlu or mGlu receptor subtypes that participate in a range of central synaptic processes, including synaptic plasticity. British Journal of Pharmacology(2006)147, S100–S108. doi:10.1038/sj.bjp.0706444
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Magnesium gates glutamate-activated channels in mouse central neurones
Nowak, L., Bregestovski, P., Ascher, P., Herbet, A., & Prochiantz, A. (1984) · Nature · doi:10.1038/307462a0 · Cited by 4,043
Hollmann, M., & Heinemann, S. (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.000335 · Cited by 3,975
Glutamate receptor ion channels
Mayer, M. L. (2005) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2005.05.004 · Cited by 3,640
Glycine potentiates the NMDA response in cultured mouse brain neurons
Johnson, J. W., & Ascher, P. (1987) · Nature · doi:10.1038/325529a0 · Cited by 3,139
Molecular diversity of glutamate receptors and implications for brain function
Nakanishi, S. (1992) · Science · doi:10.1126/science.1329206 · Cited by 2,543
Excitatory Amino Acid Transmitters
Watkins, J. C., & Evans, R. H. (1981) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.21.040181.001121 · Cited by 2,491
Self-citationCollingridge, G. L., Kehl, S. J., & McLennan, H. (1983) · The Journal of Physiology · doi:10.1113/jphysiol.1983.sp014478 · Cited by 2,413
Monaghan, D. T., Bridges, R. J., & Cotman, C. W. (1989) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.29.040189.002053 · Cited by 2,194
MacDermott, A. B., Mayer, M. L., Westbrook, G. L., Smith, S. J., & Barker, J. L. (1986) · Nature · doi:10.1038/321519a0 · Cited by 1,835
Amino acid transmitters in the mammalian central nervous system
Curtis, D. R., & Johnston, G. A. R. (1974) · Ergebnisse der Physiologie Reviews of Physiology, Volume 69 · doi:10.1007/3-540-06498-2_3 · Cited by 1,165
Pharmacological agents acting at subtypes of metabotropic glutamate receptors
Schoepp, D. D., Jane, D. E., & Monn, J. A. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00092-1 · Cited by 1,060
Self-citationReceptor trafficking and synaptic plasticity
Collingridge, G. L., Isaac, J. T. R., & Wang, Y. T. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1556 · Cited by 1,046
THE EXCITATION AND DEPRESSION OF SPINAL NEURONES BY STRUCTURALLY RELATED AMINO ACIDS
Curtis, D. R., & Watkins, J. C. (1960) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1960.tb13458.x · Cited by 856
Self-citationIonotropic and metabotropic glutamate receptor structure and pharmacology
Kew, J. N. C., & Kemp, J. A. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2200-z · Cited by 788
Schoepp, D. D. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29296-x · Cited by 690
The chemical excitation of spinal neurones by certain acidic amino acids
Curtis, D. R., Phillis, J. W., & Watkins, J. C. (1960) · The Journal of Physiology · doi:10.1113/jphysiol.1960.sp006410 · Cited by 498
Self-citationEVANS, R. H., FRANCIS, A. A., JONES, A. W., SMITH, D. A. S., & WATKINS, J. C. (1982) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1982.tb08758.x · Cited by 467
Self-citationBortolotto, Z. A., Bashir, Z. I., Davies, C. H., & Collingridge, G. L. (1994) · Nature · doi:10.1038/368740a0 · Cited by 427
Roles and rules of kainate receptors in synaptic transmission
Lerma, J. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1118 · Cited by 372
Structural basis for partial agonist action at ionotropic glutamate receptors
Jin, R., Banke, T. G., Mayer, M. L., Traynelis, S. F., & Gouaux, E. (2003) · Nature Neuroscience · doi:10.1038/nn1091 · Cited by 367
Tsuchiya, D., Kunishima, N., Kamiya, N., Jingami, H., & Morikawa, K. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052708599 · Cited by 346
THE PHARMACOLOGY OF AMINO ACIDS RELATED TO GAMMA-AMINOBUTYRIC ACID
CURTIS, D. R., & WATKINS, J. C. (1965) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07061-9 · Cited by 345
Self-citationKainate receptors are involved in synaptic plasticity
Bortolotto, Z. A., Clarke, V. R. J., Delany, C. M., Parry, M. C., Smolders, I., Vignes, M., Ho, K. H., Miu, P., Brinton, B. T., Fantaske, R., et al. (1999) · Nature · doi:10.1038/46290 · Cited by 325
Olverman, H. J., Jones, A. W., & Watkins, J. C. (1984) · Nature · doi:10.1038/307460a0 · Cited by 293
Self-citationEFFECTS OF SODIUM GLUTAMATE ON THE NERVOUS SYSTEM
HAYASHI, T. (1954) · The Keio Journal of Medicine · doi:10.2302/kjm.3.183 · Cited by 241
Evans, R. H., Francis, A. A., Hunt, K., Oakes, D. J., & Watkins, J. C. (1979) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1979.tb08706.x · Cited by 153
Self-citationACTIONS OF AMINO‐ACIDS ON THE ISOLATED HEMISECTED SPINAL CORD OF THE TOAD
Curtis, D. R., Phillis, J. W., & Watkins, J. C. (1997) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1997.tb06801.x · Cited by 140
Self-citationBiscoe, T. J., Evans, R. H., Francis, A. A., Martin, M. R., Watkins, J. C., DAVIES, J., & Dray, A. (1977) · Nature · doi:10.1038/270743a0 · Cited by 136
Self-citationACTIONS OF AMINO‐ACIDS ON THE ISOLATED HEMISECTED SPINAL CORD OF THE TOAD
Curtis, D. R., Phillis, J. W., & Watkins, J. C. (1961) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1961.tb01086.x · Cited by 126
Self-citationMcCulloch, R. M., Johnston, G. A. R., Game, C. J. A., & Curtis, D. R. (1974) · Experimental Brain Research · doi:10.1007/bf00237169 · Cited by 114
Patterns of Excitation of Thalamic Neurones by Amino-acids and by Acetylcholine
McLennan, H., Huffman, R. D., & Marshall, K. C. (1968) · Nature · doi:10.1038/219387a0 · Cited by 88
Dopamine and Glutamate in Psychiatric Disorders
Schmidt, W., & Reith, M. E. A. (2005) · Humana Press eBooks · doi:10.1007/978-1-59259-852-6 · Cited by 62
Kinarsky, L., Feng, B., Skifter, D. A., Morley, R. M., Sherman, S., Jane, D. E., & Monaghan, D. T. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.082990 · Cited by 43
Self-citation
Cited by
Glutamate in plants: metabolism, regulation, and signalling
Forde, B. G., & Lea, P. J. (2007) · Journal of Experimental Botany · doi:10.1093/jxb/erm121 · Cited by 1,107
The molecular biology of memory: cAMP, PKA, CRE, CREB-1, CREB-2, and CPEB
Kandel, E. R. (2012) · Molecular Brain · doi:10.1186/1756-6606-5-14 · Cited by 902
A Brief History of Long-Term Potentiation
Nicoll, R. A. (2017) · Neuron · doi:10.1016/j.neuron.2016.12.015 · Cited by 841
Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels
Hansen, K. B., Wollmuth, L. P., Bowie, D., Furukawa, H., Menniti, F. S., Sobolevsky, A. I., Swanson, G. T., Swanger, S. A., Greger, I. H., Nakagawa, T., et al. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000131 · Cited by 686
Excitotoxicity: Bridge to various triggers in neurodegenerative disorders
Mehta, A., Prabhakar, M., Kumar, P., Deshmukh, R., & Sharma, P. L. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.10.032 · Cited by 665
Metadata
- Authors
- Watkins, J. C., & Jane, D. E.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2006-01
- Volume
- 147
- Issue
- S1
- Pages
- S100-8
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1584538406
- Cited by
- 295
- References
- 33
- FWCI
- 6.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.